Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: VE416 for Treatment of Food Allergy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for VE416 investigating treatment of peanut allergy in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VE416

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: UNKNOWN